Skip to main content

Table 4 HBV DNA Status in HBsAg positive subjects by demographic and HIV status

From: Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

  AIDS (pretreatment time point) (N = 29) non-AIDS (N = 41) * Total (N = 66)
HBV DNA Detection Geometric Detection Geometric Detection Geometric
  N (%) Mean (c mL-1) N (%) Mean (c mL-1) N (%) Mean(c mL-1)
Sex:       
Female 7 (43.7)* 2.3 × 102 7 (26.9) 6.2 × 103 14 (29.2) 1.2 × 104
P-value difference 0.05 0.04 0.07 0.07 0.20 0.64
Age       
0-9 years 1 (100.0) 27.2 -- -- 1 (100.0) 2.7 × 101
10-24 years 1 (100.0) 6.7 × 102 4 (28.5) 1.1 × 104 5 (29.4) 6.3 × 103
25-34 years 5 (50.0) 2.9 × 102 1 (7.1) 6.6 × 103 6 (21.3) 4.9 × 102
35-44 years 9 (69.2) 1.9 × 102 0 (0.0) -- 9 (52.9) 1.9 × 102
45-93 years 2 (50.0) 2.2 × 103 2 (33.3) 1.9 × 103 4 (40.0) 2.0 × 103
P-value difference 0.83 0.81 0.31 0.30 0.12 0.53
HIV Status       
HIV-1 14 (58.3) 2.2 × 102 3 (21.4) 1.1 × 104 17 (40.4)* 4.3 × 102
HIV-2 2 (66.2) 1.3 × 103 3 (14.2) 2.9 × 103 5 (18.5)* 2.1 × 103
Dual Infection 2 (100.0) 2.4 × 102 1 (50.0) 1.2 × 104 3 (75.0)* 8.7 × 102
P-value difference 0.77 0.48 0.37 0.34 0.003 0.09
CD4 Count       
< 200 cells μL-1** 11 (73.3) 2.6 × 102 -- -- -- --
> 200 cells μL-1 5 (34.4) 1.8 × 102 -- -- -- --
P-value difference 0.22 0.19 -- -- -- --
Total 18 (62.0) 2.6 × 10 2 7 (16.6) 6.2 × 10 3 25 (34.2) 6.5 × 10 2
  1. *18 (62%) out of 29 AIDS patients and 7 (16.6%) out of 42 non-AIDS HBsAg individuals tested positive for HBV DNA.
  2. ** Number and percent are reported for CD4 count <200.